![](/img/cover-not-exists.png)
PNL17 A COST-UTILITY MODEL COMPARING AZILECT® (RASAGILINE) WITH STANDARD CARE AND ENTACAPONE IN THE TREATMENT OF PARKINSONIAN PATIENTS WITH MOTOR FLUCTUATIONS UNDER LEVODOPA IN FINLAND
J Hudry, J Rinne, T Keränen, L Eckert, J Cochran, C FrançoisVolume:
8
Year:
2005
Language:
english
DOI:
10.1016/s1098-3015(10)67556-0
File:
PDF, 63 KB
english, 2005